In the case of TGF-β, iron deficiency elevated the TGF-β secretion rather than reduce it, but in contrast with IL-8, FKN significantly increased the TGF-β protein levels compared to the DFO treatments (Figure 3G,H). The gene discussed is TGFB1; the disease is Iron deficiency anemia.